Australia’s Therapeutic Goods Administration (TGA) has accepted a court-enforceable undertaking from Your Solution ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...

Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug, marketed and sold as Zepbound / Mounjaro. Hims & Hers ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best beginner stocks. The US stock market has experienced a turbulent first quarter of ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as generics of Novo Nordisk's diabetes drug liraglutide through its weight loss ...

Eli Lilly and Co. is suing an Indianapolis ... the main ingredient in Mounjaro and Zepbound. Since 2023, Lilly has taken action against dozens of pharmacies, weight-loss centers and health spas ...

Eli Lilly is grabbing headlines thanks to medicines like Mounjaro for diabetes and Zepbound for weight management. However, these therapies will run out of patent protection and stop being growth ...

The active pharmaceutical ingredient (API) in Mounjaro, the weight-loss drug produced by Eli Lilly, is Ireland’s biggest pharmaceutical export to the US, and would be the hardest hit if US ...